Back to the compound target network, luteolin and quercetin were found to influence NOS3 and NOS2 tested targets directly for hypertension, future studies should recognize the role of these compounds in CIF, and pharmacokinetic parameters should be calculated in both healthy and disease. This evidence concerns the gene NOS2 and Hypertension.